文献速递颈动脉与弓上血管

透析患者可安全接受经颈动脉血运重建术

TransCarotid Artery Revascularization Can Be Safely Performed in Patients Undergoing Dialysis.
PubMed 文献 · Ann Vasc Surg · 2023-01-20

本研究基于血管质量倡议(VQI)数据库2016年11月至2021年11月接受经颈动脉血运重建术(TCAR)的22,619例患者,其中327例正在接受透析。多因素分析显示透析与非透析患者院内卒中、死亡或心肌梗死复合终点无差异,但透析患者住院时间延长风险更高(OR 1.6,95%CI 1.2-2,P<0.001),1年总生存率透析组81.5% vs 非透析组95.5%(P<0.001)。作者认为TCAR可安全用于透析患者。

要点

  • 透析患者TCAR后院内卒中、死亡或心肌梗死复合终点与非透析患者无差异。
  • 透析患者住院时间延长(>1天)风险更高(OR 1.6,95%CI 1.2-2,P<0.001)。
  • 1年总生存率透析组81.5% vs 非透析组95.5%(P<0.001)。

核心结论

  • 作者认为透析与非透析患者TCAR后卒中、死亡和心肌梗死风险无差异,因此TCAR可安全用于透析患者。
  • 作者指出未来需要更大样本量的研究来证实这些结果。

研究设计与样本

  • 回顾性队列研究,查询血管质量倡议(VQI)数据库2016年11月至2021年11月接受TCAR的患者。
  • 共22,619例患者接受TCAR,其中327例正在接受透析,其余为非透析组。
  • 主要终点为院内卒中、死亡或心肌梗死复合终点,采用多因素logistic回归分析院内结局。
  • 采用Kaplan-Meier生存分析和log-rank检验评估1年生存率。

主要发现

  • 单因素分析中透析患者死亡率高于非透析患者(1.2% vs 0.6%,P=0.030),但校正混杂因素后差异未持续(OR 1.99,95%CI 0.8-4.9,P=0.136)。
  • 透析患者住院时间延长(>1天)风险更高(OR 1.6,95%CI 1.2-2,P<0.001)。
  • 单因素和多因素分析中,透析与非透析患者在卒中或死亡、卒中、卒中或短暂性脑缺血发作、心肌梗死、卒中或死亡或心肌梗死风险方面均无差异。
  • 1年总生存率透析组81.5% vs 非透析组95.5%(P<0.001)。

临床怎么用

  • 作者认为TCAR可安全用于透析患者,但未来需更大样本量研究证实。

局限性

  • 作者指出未来需要更大样本量的研究来证实这些结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: TransCarotid Artery Revascularization (TCAR) has been effectively performed to prevent stroke in patients with carotid artery stenosis (CS). Prior studies established that TCAR can be safely performed in high-risk patients such as octogenarians, patients with prior carotid endarterectomy (CEA), contralateral occlusion, and heavily calcified lesions. Hemodialysis patients are at an increased risk of exhibiting cardiovascular complications. This study aims to investigate how dialysis may affect TCAR outcomes. METHODS: The Vascular Quality Initiative (VQI) dataset was queried for patients undergoing TCAR from November 2016 to November 2021. Patients were divided into dialysis and nondialysis groups. The primary outcome was the composite endpoint of in-hospital stroke, death, or myocardial infarction (MI). Secondary outcomes were in-hospital stroke, stroke, or transient ischemic attack (TIA), death, prolonged length of stay (more than 1 day) (PLOS), MI, and stroke or death. Multivariable logistic regression analysis was used to assess in-hospital outcomes. Kaplan-Meier survival and log-rank test were used to assess 1-year survival. RESULTS: A total of 22,619 patients underwent TCAR during the study period. Of these, 327 patients were undergoing dialysis. On univariable analysis, dialysis patients were associated with a higher risk of mortality compared to nondialysis patients (1.2% vs. 0.6%, P = 0.030). However, after adjusting for potential confounders, this difference did not persist (odd ratio [OR]: 1.99, 95% confidence interval [CI] (0.8-4.9), P = 0.136). Dialysis patients were more likely to experience PLOS (OR: 1.6, 95% CI (1.2-2), P < 0.001). There was no difference between dialysis and nondialysis patients in the risk of stroke or death, stroke, stroke or TIA, MI, and stroke or death, or MI on univariable and multivariable analyses. At 1 year, the overall survival for dialysis versus nondialysis patients was 81.5% vs. 95.5%, P < 0.001. CONCLUSIONS: To our knowledge, this is the first study to date of dialysis patients who have undergone TCAR. We have shown that there was no difference in the risk of stroke, death, and MI between dialysis and nondialysis patients. Therefore, TCAR can be safely offered to patients undergoing dialysis. Future studies with larger number of patients are warranted to confirm these results.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Elsayed N, Vasudevan RS, Zarrintan S, et al. TransCarotid Artery Revascularization Can Be Safely Performed in Patients Undergoing Dialysis. Ann Vasc Surg. 2023. PMID: 36690251. doi:10.1016/j.avsg.2023.01.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。